4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-21-036355
Chief Scientific Officer sold 30,000 shares at an average $20.16 ($604,706)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lowdell Mark William Chief Scientific Officer | 2021-07-07 | Sale | −5,850 | $20.02 | $117,117 | 1,500,401 | D: show line 1 in the form |
| Lowdell Mark William Chief Scientific Officer | 2021-07-08 | Sale | −24,150 | $20.19 | $487,589 | 1,476,251 | D: show line 2 in the form |
| Open-market sales · 30,000 sh · avg $20.16 · $604,706 | |||||||
Loading xslF345X03/ownership.xml…